Sana Biotechnology, Inc. (SANA): A Bull Case Theory
We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...
Hosted on MSN27d
SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data
Sana’s HIP technology aims to eliminate the ... In the past 30 days, estimates for CytomX Therapeutics’ 2024 loss per share have remained constant at 5 cents. Estimates for 2025 loss per ...
Business Insider27d
Lineage Cell Therapeutics price target lowered to $3 from $5 at Maxim
Maxim lowered the firm’s price target on Lineage Cell Therapeutics (LCTX) to $3 from $5 and keeps a Buy rating on the shares. Sana Biotechnology (SANA), another player in the cell transplant ...
Business Insider29d
Citi Keeps Their Buy Rating on Sana Biotechnology (SANA)
Semenkow covers the Healthcare sector, focusing on stocks such as Argenx Se, Larimar Therapeutics, and Sana Biotechnology. Sana Biotechnology has an analyst consensus of Moderate Buy, with a price ...
Seeking Alpha29d
Sana Biotechnology: Stock Price Rise Deserved Post Diabetes Cell Therapy Success
It is not just Sana that is looking to develop cell therapies that can bypass immunosuppression. Vertex and Crispr Therapeutics' Casgevy, for example, discussed above, would likely double or ...
Seeking Alpha1mon
Sana Biotechnology, Inc.
FDMT4D Molecular Therapeutics, Inc. 4D Molecular Therapeutics, Inc. IPSCCentury Therapeutics, Inc. Century Therapeutics, Inc. RVMDRevolution Medicines, Inc ...
Yahoo Finance1mon
Tenvie raises $200M for brain drug R&D; Sana spikes on single patient’s results
Stoke Therapeutics has finalized plans for a Phase 3 study testing its experimental drug for Dravet syndrome, a severe developmental disease characterized by regular seizures. According to the ...